Issue #82

Thousands of Readers Can't Be Wrong!

December 28, 2023

December 28, 2023 | Issue #82

2024 is almost here - what longevity practice are you adding to your life?

In this week's newsletter:🗓️ Our Top 5 Most Read of 2023💰 Longeveron Raises More🌐 We Obsessed Over Longevity This Year    Over the past year Spannr has published over 50 original content pieces focused on longevity.Below, are the top 5 articles that have been read by thousands of longevity enthusiasts. As we enter 2024, we'll be focusing on more ways to educate, entertain, and provide access to the nascent longevity industry. Thank you for being on this journey with us - we're excited to share our future plans and get you involved in what comes next!

  • The National Institute on Aging is hiring a Senior Program Manager APPLY HERE.

  • Browse thousands of jobs in the longevity industry, updated daily, in Spannr's new Jobs database HERE. 

  • Longeveron Inc., a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,355,301 of its shares of common stock at a purchase price of $1.745 per share in a registered direct offering priced at-the-market under Nasdaq rules (total of $2.36 million).

  • Explore Spannr's Longevity Investor database HERE.

  • We Are So Not Ready for a Society Where Living to 100 Is Common (Bloomberg)

  • A New Study of 8,000 People Shows Being Surrounded by Nature Slows Aging on a Cellular Level (Inc.)

  • This Was the Year of Obsessing Over Longevity (GQ)

  • Could dinosaurs be the reason humans can’t live for 200 years? (The Conversation)

  • ‘We’re Living Longer, But We’re Living Longer, Sicker’: Rejuve CEO (DeCrypt)

Performance:

Latest Price: $109.497d-Return: 6%Market Cap: $11.2b

Big Movers:Clene (CLNN): -44.23%Brainstorm (BCLI): 42.11%Tenaya (TNYA): 32.94%

ABOUT SPANNR

We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.

If you have any questions about Spannr or want to get to know us better, 

 – we'd love to hear from you. We appreciate your interest in what we are creating.